VFA
TGTX icon

Valeo Financial Advisors’s TG Therapeutics TGTX Stock Holding History

Valeo Financial Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
+6,033
New +$247K 0.01% 589
2025
Q2 		– Sell
-13,003
Closed -$513K – 818
2025
Q1 		$513K Sell
13,003
-529
-4% -$17.8K 0.01% 410
2024
Q4 		$407K Buy
13,532
+3,309
+32% +$95K 0.01% 458
2024
Q3 		$239K Buy
+10,223
New +$223K 0.01% 600
2024
Q2 		– Sell
-43,344
Closed -$606K – 719
2024
Q1 		$606K Sell
43,344
-19,956
-32% -$318K 0.02% 320
2023
Q4 		$1.08M Buy
63,300
+1,500
+2% +$17.4K 0.04% 213
2023
Q3 		$517K Buy
61,800
+1,500
+2% +$20.9K 0.02% 323
2023
Q2 		$1.5M Sell
60,300
-5,000
-8% -$129K 0.07% 153
2023
Q1 		$982K Sell
65,300
-3,500
-5% -$53.2K 0.05% 216
2022
Q4 		$814K Buy
68,800
+35,900
+109% +$261K 0.04% 212
2022
Q3 		$195K Sell
32,900
-9,100
-22% -$59.7K 0.01% 446
2022
Q2 		$178K Buy
42,000
+24,900
+146% +$155K 0.01% 442
2022
Q1 		$163K Sell
17,100
-5,500
-24% -$63.7K 0.01% 559
2021
Q4 		$429K Buy
22,600
+6,400
+40% +$166K 0.02% 343
2021
Q3 		$539K Buy
+16,200
New +$501K 0.03% 280
2021
Q2 		– Sell
-1,000
Closed -$48K – 1696
2021
Q1 		$48K Buy
1,000
+500
+100% +$24K ﹤0.01% 891
2020
Q4 		$26K Hold
500
– – ﹤0.01% 965
2020
Q3 		$13K Buy
+500
New +$11.5K ﹤0.01% 1027

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Valeo Financial Advisors's TGTX Position: Q2 2026 in Review

Valeo Financial Advisors opened a new position in TG Therapeutics (TGTX) in Q2 2026: 6,033 shares worth $331K. The stake represents 0.01% of the portfolio and ranks #589 among its holdings. This is a return to the name: Valeo Financial Advisors previously reported a position in TGTX as recently as Q1 2025.

Valeo Financial Advisors first reported a position in TGTX in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.5M in Q2 2023. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Valeo Financial Advisors held 6,033 shares of TG Therapeutics worth $331K as of Q2 2026.
  • TG Therapeutics was a new Valeo Financial Advisors position in Q2 2026.
  • TG Therapeutics made up 0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #589 holding.
  • Valeo Financial Advisors first reported a position in TG Therapeutics in Q3 2020 and has held it in 18 quarters since.
  • Valeo Financial Advisors's TG Therapeutics position peaked at $1.5M in Q2 2023.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.